• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

Cardiovascular Risk: Causal Association With Sleep Apnea “Hard to Establish” Until Now

October 31, 2013 by admin

Researchers from Brigham and Women’s Hospital Results indicate that obstructive sleep apnea is associated with subclinical myocardial injury—and that high-sensitivity troponin T may serve as an early marker of the adverse myocardial impact of obstructive sleep apnea.

“Although obstructive sleep apnea is associated with increased cardiovascular risk, a causal association has been hard to establish because of the association of obstructive sleep apnea with other risk factors,” said Amil M. Shah, MD, MPH, of Brigham and Women’s Hospital. “In a new study, we were able to demonstrate that greater obstructive sleep apnea severity is independently associated with higher high-sensitivity troponin T levels, suggesting a role for subclinical myocardial injury in the relationship between obstructive sleep apnea and heart failure.”

Cardiology Today reports that this is the first study to demonstrate an independent association between sleep apnea severity and this marker of early myocardial injury.

The new study titled “Sleep Apnea is Associated with Subclinical Myocardial Injury in the Community: The ARIC-SHHS Study” included 1,645 middle-aged and older participants in the Atherosclerosis Risk in Communities (ARIC) study and the Sleep Health Study. All were free of CHD and HF at baseline.

Read Abstract Here

According to Cardiology Today, median follow-up was 12.4 years. Participants underwent overnight home polysomnography. Obstructive sleep apnea severity, measured by the respiratory disturbance index (RDI), was categorized as none (RDI ≤5), mild (RDI 5-15), moderate (RDI 15-30) or severe (RDI ≥30).

High-sensitivity troponin T levels, but not NT-proBNP levels, were significantly associated with obstructive sleep apnea after adjustment for 17 potential confounders (P=.02). In all obstructive sleep apnea severity categories, high-sensitivity troponin T was significantly related to the risk for death or incident HF; this relationship was strongest in the severe obstructive sleep apnea group.

Limitations of the study include its cross-sectional design and a limited number of participants with obstructive sleep apnea. “Our results suggest a relationship between subclinical myocardial injury and the increased cardiovascular risk seen in patients with obstructive sleep apnea,” Shah said. “Monitoring of high-sensitivity troponin T levels in these patients may have prognostic value, particularly in patients with severe obstructive sleep apnea.”

Source: ATS Journals

Filed Under: Articles, Blog

Primary Sidebar

More to See

Snoring, American Sleep and Breathing Academy and the NY Times

August 23, 2022 By admin

Jazz Pharma Presents 17 New Posters for SLEEP 2022

June 6, 2022 By admin

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • SUPPORT AND PROMOTE DENTAL SLEEP MEDICINE IN 2023!
  • Snoring, American Sleep and Breathing Academy and the NY Times
  • Jazz Pharma Presents 17 New Posters for SLEEP 2022
  • AJMC Hypes SLEEP 2022
  • Avadel Pharmaceuticals’ Stock Falls

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2023 · Sleep Diagnosis and Therapy